Lindera Obtusiloba for Non-small Cell Lung Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This randomized, open labelled, non-treatment-controlled study evaluates the safety and efficacy of Lindera obtusiloba, a dietary food, on quality of life of non-small cell lung cancer patients who are receiving PD-1 or PD-L1 inhibitors.
Epistemonikos ID: c642ba2f6eb080eaccad384f80ae3b479eede6ac
First added on: May 07, 2024